ELISA

The RayBiotech Influenza Virus A H3N2 Hemagglutinin / Human Galectin-1 Ligand Binding Assay Kit characterizes the binding affinity of H3N2 Hemagglutinin and Human Galectin-1 in the presence of potential inhibitors. This product is for research use only. Not for therapeutic or diagnostic applications. 4-8 week development phase.

The RayBiotech Influenza Virus A H3N2 Hemagglutinin / Human Galectin-1 Ligand Binding Assay Kit characterizes the binding affinity of H3N2 Hemagglutinin and Human Galectin-1 in the presence of potential inhibitors. This product is for research use only. Not for therapeutic or diagnostic applications. 4-8 week development phase.

The RayBiotech Influenza Virus A H3N2 Hemagglutinin / Human Galectin-1 Ligand Binding Assay Kit characterizes the binding affinity of H3N2 Hemagglutinin and Human Galectin-1 in the presence of potential inhibitors. This product is for research use only. Not for therapeutic or diagnostic applications. 4-8 week development phase.

The RayBiotech Avian Influenza Virus (bird flu) H5N1 Hemagglutinin / Human Galectin-1 Ligand Binding Assay Kit characterizes the binding affinity of H5N1 Hemagglutinin and Human Galectin-1 in the presence of potential inhibitors. This product is for research use only. Not for therapeutic or diagnostic applications. 4-8 week development phase.

The RayBiotech Avian Influenza Virus (bird flu) H5N1 Hemagglutinin / Human Galectin-1 Ligand Binding Assay Kit characterizes the binding affinity of H5N1 Hemagglutinin and Human Galectin-1 in the presence of potential inhibitors. This product is for research use only. Not for therapeutic or diagnostic applications. 4-8 week development phase.

The RayBiotech Avian Influenza Virus (bird flu) H5N1 Hemagglutinin / Human Galectin-1 Ligand Binding Assay Kit characterizes the binding affinity of H5N1 Hemagglutinin and Human Galectin-1 in the presence of potential inhibitors. This product is for research use only. Not for therapeutic or diagnostic applications. 4-8 week development phase.

The HPV11 E7/pRb Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 11 E7 oncoprotein and its receptor Retinoblastoma in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The HPV11 E7/pRb Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 11 E7 oncoprotein and its receptor Retinoblastoma in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The HPV11 E7/pRb Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 11 E7 oncoprotein and its receptor Retinoblastoma in the presence of potential inhibitors within 4 hours. 4-8 week development phase.